Skip to main navigation Skip to search Skip to main content

Correction to: CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin–proteasome pathway in ER + breast cancer (Clinical and Translational Oncology, (2022), 24, 11, (2120-2135), 10.1007/s12094-022-02881-0)

  • Chih Yi Lin
  • , Chung Jen Yu
  • , Chun Yu Liu
  • , Ta Chung Chao
  • , Chi Cheng Huang
  • , Ling Ming Tseng
  • , Jiun I. Lai*
    • *Corresponding author for this work

Research output: Contribution to journal › Comment/debate

Fingerprint

Dive into the research topics of 'Correction to: CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin–proteasome pathway in ER + breast cancer (Clinical and Translational Oncology, (2022), 24, 11, (2120-2135), 10.1007/s12094-022-02881-0)'. Together they form a unique fingerprint.
Sort by

Keyphrases

Biochemistry, Genetics and Molecular Biology